Cargando…
Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases
PURPOSE: Sarcopenia has been identified as a prognostic marker of clinical outcomes in several diseases. However, the influence of sarcopenia on non-surgical local treatments in breast cancer liver metastases (BCLM) is unknown. Therefore, the purpose of this study was to assess the effect of sarcope...
Autores principales: | Thormann, Maximilian, Heitmann, Franziska, March, Christine, Pech, Maciej, Hass, Peter, Surov, Alexey, Damm, Robert, Omari, Jazan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528834/ https://www.ncbi.nlm.nih.gov/pubmed/36199942 http://dx.doi.org/10.5114/jcb.2022.119515 |
Ejemplares similares
-
Needle track seeding in colorectal carcinoma after local ablation by high-dose-rate brachytherapy: a retrospective study of 1,107 catheter placements
por: March, Christine, et al.
Publicado: (2022) -
Radiation exposure to the kidney with interstitial iridium-192 high-dose-rate brachytherapy: Extent and rare morphologic changes of radiation nephropathy
por: March, Christine, et al.
Publicado: (2022) -
Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (HDR) brachytherapy of liver metastases
por: Damm, Robert, et al.
Publicado: (2022) -
Efficacy and safety of percutaneous computed tomography-guided high-dose-rate interstitial brachytherapy in treatment of oligometastatic lymph node metastases of retroperitoneal space
por: Heinze, Constanze, et al.
Publicado: (2019) -
Treatment of hepatic pancreatic ductal adenocarcinoma metastases with high-dose-rate image-guided interstitial brachytherapy: a single center experience
por: Drewes, Ralph, et al.
Publicado: (2019)